Alkermes plc

ALKS Stock Healthcare Biotechnology
$47.41
-1.49 (-3.05%)
Price as of Aug 28, 2026 market close

Performance

1 Month
-5.2%
3 Months
+12.4%
YTD
+69.4%
1 Year
+62.1%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
41.2%
Largest decline max drawdown, since Aug 2025
-22.2%
Risk-adjusted return Sharpe ratio, 1-year
1.38

Own ALKS?

See how ALKS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.